belinostat trade name beleodaq previously known histone deacetylase inhibitor drug developed topotarget treatment hematological malignancies solid approved july us fda treat peripheral tcell preliminary results released phase ii clinical trial intravenous belinostat combination carboplatin paclitaxel relapsed ovarian final results late phase ii trial tcell lymphoma belinostat granted orphan drug fast track designation approved us use peripheral tcell lymphoma july approved europe august approved pharmaceutical formulation given belinostat primarily metabolized initial dose reduced recipient known homozygous antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikibelinostat